These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19320649)

  • 1. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
    Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
    Hattori N; Ishihara T; Saiki Y; Shimatsu A
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and radiological features of patients with macroprolactinaemia.
    Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference by macroprolactin in assays for prolactin: will the
    Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP
    Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
    Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
    Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM; Smith TP; Gibney J; McKenna TJ
    Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum.
    Ellis AR; Fahie-Wilson M; Axcell M; Sands K; Hill RP
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):57-62. PubMed ID: 16390610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of macroprolactin by precipitation and ultrafiltration methods.
    Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
    Olukoga AO; Kane JW
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.